AUG 30, 2016 08:00 AM PDT

From millions to billions to trillions - translating your cell discovery into a cell product

  • Vice President, Technology and Director, BridGE at CCRM, Canada
      Nick is VP, Technology, and Director, BridGE at CCRM. A bioprocess engineering by training, his career has focused on the development of manufacturing process for cellular therapies. Following undergraduate studies in New Zealand he gained his PhD in Australia, did a post-doc in Switzerland, returned to Australia as a research Team Leader, and in 2011 relocated to Canada to join CCRM.

    A key aspect of translating great scientific discoveries to commercially viable cell therapies is the establishment of robust manufacturing processes that can produce the right quantity of cells, of the right quality, at the right cost, at the right time. In many instances a significant challenge lies in moving from the generation of millions of cells in the research lab to trillions of cells in compliance with regulatory requirements and Good Manufacturing Practices. There is no single path to achieving this, but establishing your vision early and asking the right questions can build a solid foundation from which to pursue future success. This presentation will explore some of these early considerations and why they are important.

    Show Resources
    Loading Comments...